(Q47637749)

4 February 2018

title

Factors that influence adherence with disease-modifying therapy in MS. (English)

1 reference

4 February 2018

21

Olaf Stüve

1 reference

4 February 2018

2

Gary Cutter

0 references

author name string

Katherine Treadaway

1

1 reference

4 February 2018

Amber Salter

3

1 reference

4 February 2018

Sharon Lynch

4

1 reference

4 February 2018

James Simsarian

5

1 reference

4 February 2018

John Corboy

6

1 reference

4 February 2018

Douglas Jeffery

7

1 reference

4 February 2018

Bruce Cohen

8

1 reference

4 February 2018

Ken Mankowski

9

1 reference

4 February 2018

Joseph Guarnaccia

10

1 reference

4 February 2018

Lawrence Schaeffer

11

1 reference

4 February 2018

Roy Kanter

12

1 reference

4 February 2018

David Brandes

13

1 reference

4 February 2018

Charles Kaufman

14

1 reference

4 February 2018

David Duncan

15

1 reference

4 February 2018

Ellen Marder

16

1 reference

4 February 2018

Arthur Allen

17

1 reference

4 February 2018

John Harney

18

1 reference

4 February 2018

Joanna Cooper

19

1 reference

4 February 2018

Douglas Woo

20

1 reference

4 February 2018

Michael Racke

22

1 reference

4 February 2018

Elliot M Frohman

23

1 reference

4 February 2018

publication date

27 April 2009

1 reference

4 February 2018

published in

Journal of Neurology

1 reference

4 February 2018

volume

256

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

568-576

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-009-0096-y

exact match

0 references

cites work

Symptomatic therapy for underrecognized manifestations of multiple sclerosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-009-0096-Y

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-009-0096-Y

Depression and multiple sclerosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00415-009-0096-Y

21 January 2018

1 reference

12 December 2020

Disease-modifying therapy in multiple sclerosis: strategies for optimizing management

1 reference

12 December 2020

Abbreviated instrument to measure hope: development and psychometric evaluation

1 reference

12 December 2020

Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program

1 reference

12 December 2020

Predictors of adherence to glatiramer acetate therapy in individuals with self-reported progressive forms of multiple sclerosis.

1 reference

12 December 2020

Psychosocial factors associated with adherence to antiretroviral medications in a sample of HIV-positive African American drug users

1 reference

12 December 2020

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

12 December 2020

Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Adherence in adolescents and young adults following heart or heart-lung transplantation.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus.

1 reference

12 December 2020

Medication-taking beliefs of adult renal transplant recipients

1 reference

12 December 2020

Depression and multiple sclerosis: Review of a lethal combination

1 reference

12 December 2020

Forgetfulness: a role in noncompliance with antidepressant treatment

1 reference

12 December 2020

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

1 reference

12 December 2020

An inquiry into medication meanings, illness, medication use, and the transformative potential of chronic illness among African Americans with hypertension

1 reference

12 December 2020

Medication-taking behavior in a cohort of patients with inflammatory bowel disease

1 reference

12 December 2020

10.1007/S00415-009-0096-Y

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018